News Releases

1 ... 32 33 34 35 36 ... 39

April 25, 2016

OrganiGram Reports Results for Fiscal Q2 2016

Moncton, New Brunswick, April 25th, 2016 – OrganiGram Holdings Inc. (TSX-V: OGI, OTCQB: OGRMF) (the “Company”) today reported its financial results for the second quarter ending February 29th, 2016.
April 12, 2016

OrganiGram Announces Positive Cash Flow and Earnings

Moncton, New Brunswick, April 12th, 2016 – Organigram Holdings Inc. (TSX-V: OGI, OTCQB: OGRMF) (the “Company”) provides a preliminary synopsis of its 2nd quarter results.
April 8, 2016

Meet the Team: Nicole, Client Services

How long have you been working at OrganiGram?I have been working at OrganiGram for just over six months. What was your background prior to joining the team at OrganiGram?Prior to joining...
April 1, 2016

Dundee Capital Markets Upgrades OrganiGram to Buy on Honed Strategy and Provincial Funding

We are pleased to report Dundee Capital Markets has upgraded OrganiGram Holdings to a BUY, with a $1.00 Target price from $0.90 on the back of an increased valuation multiple...
March 30, 2016

Organigram Announces Provincial Government Funding

Moncton, New Brunswick, March 30th, 2016 – OrganiGram Holdings Inc. (TSX-V: OGI, OTCQB: OGRMF) (the “Company”) announces a collaboration with the Province of New Brunswick through Opportunities NB Inc. (ONB).

1 ... 32 33 34 35 36 ... 39

Have a question for us?

Call 1-844-644-4726 (1-844-OGI-GRAM) and the folks on our client support team like Dan, Janice and Jeff can answer any question you have.

Monday to Thursday: 8:30 AM to 8:00 PM 
Friday: 8:30 AM to 6:30 PM 
Fax: 1-855-267-1386

Stay informed. #DiscoverOGI.

Interested in keeping up with Organigram news? Subscribe to our mailing lists and stay up-to-date on Organigram products, patient programs, company news and investor relations. 

By signing up, I acknowledge that I can unsubscribe at any time, and I accept the terms, conditions and privacy policy.

If you wish to receive newsletters from Organigram Holdings Inc. and its subsidiaries, please provide your email address and click on the “Subscribe” button above. If we do not receive your consent, we may be unable to send you communications. If you have any questions, or if you wish to withdraw your consent at any time, please feel free to contact us by phone at 1-844-644-4726 or by email at By clicking “Subscribe” I consent to receipt of communications as indicated above.